These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 30820689)
1. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy. Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689 [TBL] [Abstract][Full Text] [Related]
2. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. Taghizadehghalehjoughi A; Hacimuftuoglu A; Cetin M; Ugur AB; Galateanu B; Mezhuev Y; Okkay U; Taspinar N; Taspinar M; Uyanik A; Gundogdu B; Mohammadzadeh M; Nalci KA; Stivaktakis P; Tsatsakis A; Jung TW; Jeong JH; Abd El-Aty AM Nanomedicine (Lond); 2018 Jul; 13(13):1595-1606. PubMed ID: 30028222 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral Injection Administration of Irinotecan-Loaded Microspheres: In Vitro and In Vivo Evaluation. Zhu S; Dou M; Huang G AAPS PharmSciTech; 2018 Nov; 19(8):3829-3838. PubMed ID: 30280351 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
6. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer. Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589 [TBL] [Abstract][Full Text] [Related]
7. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells. Rahimnia SM; Saeedi M; Akbari J; Morteza-Semnani K; Hedayatizadeh-Omran A; Yazdian-Robati R AAPS PharmSciTech; 2024 Jun; 25(6):141. PubMed ID: 38898204 [TBL] [Abstract][Full Text] [Related]
8. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574 [TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
12. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288 [TBL] [Abstract][Full Text] [Related]
13. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]
14. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. Song X; Wang J; Xu Y; Shao H; Gu J Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022 [TBL] [Abstract][Full Text] [Related]
16. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
17. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
18. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines. Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665 [TBL] [Abstract][Full Text] [Related]